θǻÄÚÊÖÊõ,Intragastric surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Äæ×ªÂ¼³²Ê½¾ÛºÏøÁ´·´Ó¦,reverse transcription-nested polymerase chain reactionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹Ü°©êÚÃŰ©,opha-geal and Cardiac CarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CD44Æ´½Ó±äÒìÌåv6,CD44 splice variant v6Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»îÌåÖí¸Î,Live pig liverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ä¤ºó¸±Éñ¾½ÚÁö,retroperinoneal paragangliomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ñÐÔ¼äÖÊÁö,Malignant stromal tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×ÁöÏà¹ØÎïÖÊ(TSGF),tumor specific growth factors (TSGF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θ²Ð°©,Gastic stumpÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ç»¶ñÐÔÖ×Áö,malignant abdominal tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎÊ®¶þÖ¸³¦ÈÍ´ø¹Ç÷À»¯,Skeletonization of the hepatoduodenal ligamentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ìǵ÷½Úµ°°×,glucose-regulated proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Æ÷еÎǺÏ,anus-preserving operationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
賦¶ñÐÔÖ×Áö,Malignant gastrointestinal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´óÊó¸Î°©,primary liver cancer of ratÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²ÊÜÒæ,clinical benefitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇàÄêÈËθ°©,Gastric cancer in the yongÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚÖ§¼ÜÖÃÈëÊõ,Endovascular stent placementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ó¾±²¿ÎǺÏ,Anastomosis through the left neckÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÀªÈë¿Ú,Malignant tumo rÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÒÐØÇ°Íâ²àÇпÚ,right anterolateral thoracotomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÎ̬ѧ±ê×¼,Morphological standardÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½á³¦°©Ï¸°ûϵ,colonic cancer cell linesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ä¤Ö×Áö/Õï¶Ï,Peritoneal neoplasms/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ä¤Ö×Áö/ÖÎÁÆ,Peritoneal neoplasms/therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
WelchÊÖÊõ,Welch operationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËʳ¹Ü°©,human esophageal cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θÖ×Áö/¼Ì·¢ÐÔ,STOMACH NEOPLASMS/secondÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹£×èÐԴ󳦰©,obstructive carcinoma of colonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
125I×ÑÔ´,125 I seedsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö÷¶¯ÂöËðÉË,Aortic injuryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓªÑøÉÅ,nutritional dietÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Ö²¿¸´·¢ÂÊ,Local recurrence rateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éú³¤×ªÒÆ,Tumor Growth and MetastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Îϸ°û»îÁ¦,Activity of hepatocytesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CA24-2,CA24 2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹Ü°©/êÚÃŰ©,Oesophageal cancer/cardiac cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ó³¦ÏÙÁöÐÔÏ¢Èâ,colorectal adenomatous polypÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßƵ͸ÈÈ,high frequency diathermyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Þ²ÂöÆÚ,portal veinous phaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Dixon,Dixon CLC number:R735.37 Document code:AÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÏÙÖ×Áö/·ÅÉäÉãÓ°Êõ,pancreatic neoplasms/RAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ð¤ÒºÏ¸°û°©,Mucinous cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ת»¯Éú³¤Òò×Ó¦ÂÐÍÊÜÌå,Transforming growth factor¦Â receptor¢ñÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
©ÕïÎóÕï,wrong diagnosis and escapeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
5-Ö¬ÑõºÏøÒÖÖÆ¼Á,lipoxygenase inhibitorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Î¶¯Âö²å¹Ü»¯ÁÆË¨ÈûÊõ,embolism for hepatic artery catheterization therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÚÍ·×¢ÉäÒº,Aconite InjectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±²¿Ê³¹ÜθÎǺÏÊõ,Cervical esophagogastrostomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹Ü°©Çгý,resection of esophageal cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àÔ·¢´ó³¦°©,Multi-originate colon carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳµÀÈéÍ·×´Áö,esophageal papillomesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿Õ³¦Ôì¿Ú¹Ü,Jejunostic tubeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CA199¿¹Ô,CA 19 9 antigenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Сϸ°û/ÖÎÁÆ,small cell/pa thologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ѪС°åÒò×Ó,platelet factorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹²´æ²¡,incoporate diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
RouxÓÙ»ý×ÛºÏÕ÷,Roux stasis syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÅжÏÔ¤ºó,Prognostic judgementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
êÚÃŰ©Êõºó,postoperative cardiac carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍíÆÚθÖ×Áö,Abvanced gastric carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍλǰÇгý,low pre sacrum resection(LPR)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¡¶¾ÁÆ·¨,virus therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ó°ë½á³¦¹£×è,Left colonic obstructionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼äÖÊÁö/²¡Àíѧ,Stromal tumor/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊäÄò¹Ü¹£×è/²¡Òòѧ,Ureteral obstruction/etiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼äÖÊ·´Ó¦,stroma reactionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µç×Ӵ󳦾µ,Video colonoscopeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Î°©¿¹Ô,HCC antigenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÏÙÁ¼ÐÔÖ×Áö,Pancreatic benign tumourÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½þÈóÁܰÍϸ°û,infiltrating lymphocyteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ճĤ°þÀë,endoscopic mucosa resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¬µÍλǰÇгýÊõ,ultralow anterior resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HLA-DP,HLA DPÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
A3ÏÙÜÕÊÜÌå,A 3 adenosine receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶¯Âö²å¹Ü»¯ÁÆ,chemotherapy via arterial catheterizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»·¼ÓÑõøÒÖÖÆ¼Á,Cycol-oxygenase inhibitorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ßÅßáÇèÂÌÅÅйÊÔÑé,indocyanine green excretive testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
AFPÒìÖÊÌå,alpha-fetoprotein heterogeneityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¼¹ÜÄÚÈéÍ·×´Õ³ÒºÐÔÖ×Áö,Intraductal papillary mucinous tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½¡Æ¢ÀíÆø·½,Jianpiliqi FormulaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÞÁöÉú´æ,Auto-neoplastic vaclineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÝÐýÌå²ãÉãÓ°Êõ,Spiral TomographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄáÁúȦÌ×Ôú,Nylon Snares` LigationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßƵµçÄýÇгý,High Frequency ElectrocogulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
p27kip,p27 kipÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àÒ©ÄÍҩϸ°û,Multi-drug resistance cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎÑùÏÙ°©,Hepatoid adenocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚ½éÈë·ÅÉäÖÎÁÆ,internal radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
賦¼¤ËØÀà/·ÖÎö,GASTROINTESTINAL HORMONES/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θ²¿²¡±ä,stamoch diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÎÁÆÓëÔ¤ºó,Treatment and prognosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö²Èëʽµ¼¹ÜÒ©ºÐϵͳ,Implanted duct-reservoir systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
VEGFÒÖÖÆ¼Á,anti-VEGF agentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈýÒ°Çåɨ,three-field lymph node sweepingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Î¶¯Âö²å¹Ü,Hepatic artrictranscatheterÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒûË®·¨,Method of water drinkingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Ö×Ó±êÇ©,genetic tagsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
NKϸ°ûɱÉË»îÐÔ,NK cytotoxic indexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
˫ǻθ¾µ,double cavity gastrofiberscopeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|